Back to search
FDAFDA · Food and drugs·Recall number D-0551-2026

PRED MILD, prednisolone acetate ophthalmic suspension, USP, 0.12%, 10 mL, Sterile, Rx only, Allergen, Inc., an AbbVie company, North Chicago, IL 60064, Product of France, NDC 11980-174-10.

Published June 3, 2026 · Recall initiated: May 18, 2026

Summary

FDA records drug Class III recall D-0551-2026, published June 3, 2026 and initiated May 18, 2026. Recalling firm: AbbVie Inc.; Status: Ongoing; Reported quantity: 2,736 bottles; Lot: Lot # 402805, 407596, Exp Date: 08/2026. Class III means the product is not likely to cause adverse health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Stability Specifications

What to do

Voluntary: Firm initiated · Letter

Get an email if PRED MILD has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
PRED MILD
Manufacturer
AbbVie Inc.
Distributor
US Nationwide.
UPC
0311980174101
Lot
Lot # 402805, 407596, Exp Date: 08/2026.
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was PRED MILD, prednisolone acetate ophthalmic suspension, USP, 0.12%, 10 mL, Sterile, Rx only, Allergen, Inc., an AbbVie company, North Chicago, IL 60064, Product of France, NDC 11980-174-10. recalled?

Yes. FDA published recall D-0551-2026 on June 3, 2026. Reported hazard: Failed Stability Specifications

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: PRED MILD. UPC: 0311980174101.